Business Wire

FIA President Mohammed Ben Sulayem Leads Fight Against Online Abuse, Bringing Global Leaders Together in Stockholm

10.9.2025 18:22:00 CEST | Business Wire | Press Release

Share

The Fédération Internationale de l'Automobile (FIA), the global governing body for motorsport and the federation for mobility organisations worldwide, has welcomed industry experts and thought leaders to Stockholm, Sweden, for the second global United Against Online Abuse (UAOA) conference.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910299906/en/

FIA President and UAOA Founder, Mohammed Ben Sulayem, speaking at the second global United Against Online Abuse (UAOA) conference.

Bringing together voices from the world of sport, politics, and social media, the coalition reaffirmed their collective commitment to combatting online abuse, welcoming new members and sharing knowledge, innovation, and tools to accelerate progress in tackling this digital threat.

Joined by high-profile attendees united in UAOA’s mission of eradicating online hate and creating a safer digital environment, FIA President and UAOA Founder, Mohammed Ben Sulayem, opened the conference stating:“We are united by one goal: to protect sport from online abuse. As a force for good it inspires us, brings us together, and teaches us respect, teamwork, and discipline.

“Our community is growing – more athletes, more fans, more volunteers, more officials. But with this growth comes risk, and we must protect our community. This conference is not simply a meeting of minds; it is a declaration of our common purpose. Together we learn, build new alliances, and strengthen our voices. Together we will deliver lasting change.”

Launched in 2023 and supported by the FIA Foundation, the UAOA campaign seeks to drive both regulatory and behavioural change in response to the growing threat of online harassment. In the last two years, UAOA has released groundbreaking research, spearheaded global awareness campaigns, and brought together key stakeholders to promote respectful and inclusive digital spaces.

During the conference, the coalition welcomed two new charter signatories, Signify Group and the International Federation for Sport Officials (IFSO), joining over 70 partners including global governments and industry organisations who have already committed to this important cause.

Ben Sulayem said: “The FIA launched the United Against Online Abuse campaign to protect athletes, officials, volunteers and fans from digital harm. To win this battle it requires a combined global approach across sports, tech, government and academia, united behind a common mission. We are very excited to welcome Signify and IFSO and their pioneering work in this field to our coalition as they will strengthen our ability to combine research, regulation and innovation in driving meaningful change worldwide.”

This conference is a significant milestone for the UAOA campaign, firmly establishing it as the leading global coalition against online abuse in sport, bringing together sports federations, national governments, regulatory bodies, and technology platforms. To date, the UAOA coalition has welcomed endorsements from the Governments of Greece, France, Slovenia, Albania, Australia, Kenya, Costa Rica, Namibia, Georgia, Paraguay, and Rwanda, alongside sport federations and organisations such as FIM, ARISF, IFAF, the International Esports Federation, ASETEK SimSports, Peace and Sport Monaco, UNESCO, the Council of Europe, Clark Hill LLP, Arwen.AI and DCU University.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250910299906/en/

Contacts

Geraldine Sherwin, Director of Presidential & Mobility Communications:
gsherwin@fia.com
Joseph Kidd, Presidential Communications Officer: jkidd@fia.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye